Factors affecting topotecan sensitivity in human leukemia samples. 1996

S H Kaufmann, and S D Gore, and L Letendre, and P A Svingen, and T Kottke, and C A Buckwalter, and R J Jones, and L B Grochow, and P J Burke, and R C Donehower, and E K Rowinsky
Department of Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA. Kaufmann.Scott@Mayo.edu

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D002166 Camptothecin An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity. Camptothecine
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005544 Forecasting The prediction or projection of the nature of future problems or existing conditions based upon the extrapolation or interpretation of existing scientific data or by the application of scientific methodology. Futurology,Projections and Predictions,Future,Predictions and Projections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

S H Kaufmann, and S D Gore, and L Letendre, and P A Svingen, and T Kottke, and C A Buckwalter, and R J Jones, and L B Grochow, and P J Burke, and R C Donehower, and E K Rowinsky
January 1978, Intervirology,
S H Kaufmann, and S D Gore, and L Letendre, and P A Svingen, and T Kottke, and C A Buckwalter, and R J Jones, and L B Grochow, and P J Burke, and R C Donehower, and E K Rowinsky
January 1971, Annali dell'Istituto superiore di sanita,
S H Kaufmann, and S D Gore, and L Letendre, and P A Svingen, and T Kottke, and C A Buckwalter, and R J Jones, and L B Grochow, and P J Burke, and R C Donehower, and E K Rowinsky
January 2004, British journal of cancer,
S H Kaufmann, and S D Gore, and L Letendre, and P A Svingen, and T Kottke, and C A Buckwalter, and R J Jones, and L B Grochow, and P J Burke, and R C Donehower, and E K Rowinsky
January 1977, Nutrition and metabolism,
S H Kaufmann, and S D Gore, and L Letendre, and P A Svingen, and T Kottke, and C A Buckwalter, and R J Jones, and L B Grochow, and P J Burke, and R C Donehower, and E K Rowinsky
March 1995, Cancer,
S H Kaufmann, and S D Gore, and L Letendre, and P A Svingen, and T Kottke, and C A Buckwalter, and R J Jones, and L B Grochow, and P J Burke, and R C Donehower, and E K Rowinsky
December 2015, Oncology letters,
S H Kaufmann, and S D Gore, and L Letendre, and P A Svingen, and T Kottke, and C A Buckwalter, and R J Jones, and L B Grochow, and P J Burke, and R C Donehower, and E K Rowinsky
October 2020, Korean journal of ophthalmology : KJO,
S H Kaufmann, and S D Gore, and L Letendre, and P A Svingen, and T Kottke, and C A Buckwalter, and R J Jones, and L B Grochow, and P J Burke, and R C Donehower, and E K Rowinsky
January 1975, Problemy tuberkuleza,
S H Kaufmann, and S D Gore, and L Letendre, and P A Svingen, and T Kottke, and C A Buckwalter, and R J Jones, and L B Grochow, and P J Burke, and R C Donehower, and E K Rowinsky
October 1991, Brain : a journal of neurology,
S H Kaufmann, and S D Gore, and L Letendre, and P A Svingen, and T Kottke, and C A Buckwalter, and R J Jones, and L B Grochow, and P J Burke, and R C Donehower, and E K Rowinsky
January 2017, PeerJ,
Copied contents to your clipboard!